Viewing Study NCT04912856

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-01-07 @ 8:31 PM
Study NCT ID: NCT04912856
Status: TERMINATED
Last Update Posted: 2025-02-14
First Post: 2021-05-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
Sponsor: Xenon Pharmaceuticals Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
None Epilepsy in Children View
None Epilepsy; Seizure View
None Disease View
None Brain Diseases View
None Central Nervous System Diseases View
None Nervous System Diseases View
None Epileptic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None XEN496 View
None Ezogabine View
None Retigabine View
None Encephalopathy View
None Seizure View
None KCNQ2 View
None EPIK View